SCHEMBL22238739

SCHEMBL22238739

CN(C)c1cccc2c(S(=O)Oc3ccc(CO[N+](=O)[O-])cc3)cccc12

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 1/20 0.32
▸ RXRA P19793 1/20 0.32
▸ RXRB P28702 1/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ HIF1A Q16665 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CA2 P00918 2/20 0.31
▸ TLR4 O00206 1/20 0.31
▸ TLR2 O60603 1/20 0.31
▸ CYP19A1 P11511 1/20 0.30
▸ CA12 O43570 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA4 P22748 1/20 0.30
▸ CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22238689 0.85 CA12 (0.34) TDP1CA2CA12CA1CA4
SCHEMBL22238736 0.76 TYMS (0.51) TYMSCYP1A2CYP2C19HTTHIF1A
SCHEMBL30364675 0.69 CYP1A2 (0.43) RXRARXRBCYP1A2CYP2C19HTT
Trimethylammonium SCHEMBL11814440 0.64 CYP19A1 (0.45) CA2CYP19A1CA12CA1CA4
SCHEMBL30096384 0.63 CA2 (0.46) CYP1A2CYP2C19HTTHIF1ATDP1
SCHEMBL12716467 0.62 TYMS (0.49) TYMSCYP1A2CYP2C19HTTHIF1A
SCHEMBL15928851 0.61 CA12 (0.40) CA2CA12CA1CA4CA9
SCHEMBL5155604 0.61 CA12 (0.49) CA2CA12CA1CA4CA9
SCHEMBL5148856 0.61 AGXT (0.48) CA2CYP19A1CA12CA1CA4
SCHEMBL22664722 0.60 CA12 (0.34) TDP1CA2CA12CA1CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3049386-B1 COMPOUNDS USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES UNIV KOELN (DE) 2020-07-22 — — EP disclosed
Send feedback